Patent License Agreement with a Vision to Improved Infertility Treatment

Printer-friendly versionPDF version

Unisense FertiliTech A/S receives exclusive license for use of Visible™ Discovery Platform for time-lapse assisted embryo assessment with the EmbryoScope™ Embryo Monitoring System.

Aarhus, Denmark May 26, 2009 (PressReleasePoint) Unisense FertiliTech A/S, a Danish company which has developed the
EmbryoScope™ Embryo Monitoring System for use in in-vitro fertilization (IVF), has entered into a patent license agreement with Reify Corporation, Cambridge, Massachusetts, USA.

Under the terms of the agreement, Unisense FertiliTech A/S receives an exclusive license to utilize Reify’s Visible™ Discovery Platform in the development of critical event detection and time-lapse analysis software for ooctyes and embryo development. This technology will be provided for use with the EmbryoScope™ Embryo Monitoring System, in an IVF clinical setting. Unisense FertiliTech A/S will also receive non-exclusive development rights from Reify for stem cell analysis research with defined exceptions. Under the terms of the agreement Reify receives a combination of annual guaranteed payments and royalties.

During IVF treatments, multiple oocytes are fertilized in-vitro, and the resulting embryos are grown in an incubator until they are transferred back to the patient 2 to 5 days later. A major challenge for the embryologist, is to select the best embryo with the greatest potential to result in a full-term pregnancy. Currently embryologists spend less than a few minutes over several days observing the embryos in order to minimize disruption to development.

Access to the Reify analysis algorithms will allow Unisense FertiliTech A/S to strengthen the embryo analysis function of their EmbryoScope™ Monitoring System, and facilitate time-lapse enabled embryo selection, with minimal disruption to the developing embryo.

Reify Corporation develops and markets machine vision and video analysis software-based phenotypic screens for the biotechnology and pharmaceutical industries. For more information visit their website at http://www.reifycorp.com

Unisense FertiliTech A/S is a Danish biomedical company specialized in developing and manufacturing products for Assisted Reproductive Technology (ART). The company was founded in 2003, and is involved in international research collaborations in the area of embryo assessment and analysis with a specific focus in the IVF industry. For more information about the company, contact us at info@fertilitech.com or visit our website at http://www.fertilitech.com

Contact Info:
Unisense FertiliTech A/S
Contact person: Francesca Bahr
Sales and Marketing Manager
Office Phone: +45 89449525
Mobile Phone: +45 40255538
fab@fertilitech.com
http:// www.fertilitech.com

END